Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Pichamol Jirapinyo, Thomas R. McCarty, Russell D. Dolan, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 3, pp. 511-524.e1
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1797-1835
Open Access | Times Cited: 1159
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
Endocrine Practice (2022) Vol. 28, Iss. 5, pp. 528-562
Open Access | Times Cited: 655
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Maximilian Huttasch, Michael Roden, S. Kahl
Metabolism (2024) Vol. 157, pp. 155937-155937
Open Access | Times Cited: 35
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
Le Zhang, Mortada El‐Shabrawi, Louise A. Baur, et al.
Med (2024) Vol. 5, Iss. 7, pp. 797-815.e2
Closed Access | Times Cited: 20
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access | Times Cited: 5
Metabolic Dysfunction–Associated Steatotic Liver Disease
Sajjadh M. J. Ali, Michelle Lai
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 4
Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent Wai–Sun Wong, Mary E. Rinella, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 3
Exploring the underlying mechanisms of obesity and diabetes and the potential of Traditional Chinese Medicine: an overview of the literature
Yan-Kun Chen, Tingting Liu, Farah Khameis Farag Teia, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 25
Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease
Mohamed I. Elsaid, You Li, John F. P. Bridges, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2235003-e2235003
Open Access | Times Cited: 38
Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease
Nicholas Chew, Cheng Han Ng, Mark Muthiah, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 7, pp. 515-532
Closed Access | Times Cited: 32
MASLD treatment—a shift in the paradigm is imminent
Mariana Verdelho Machado
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18
Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach
Carmen Lara, Manuel Romero‐Gómez
European Cardiology Review (2024) Vol. 19
Open Access | Times Cited: 7
Changing clinical management of NAFLD in Asia
T. Nakatsuka, Ryosuke Tateishi, Kazuhiko Koike
Liver International (2021) Vol. 42, Iss. 9, pp. 1955-1968
Open Access | Times Cited: 29
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Ankoor Patel, Dhiraj Peddu, Sahil Amin, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 22
Liver fat as risk factor of hepatic and cardiometabolic diseases
Münevver Demir, Stefan R. Bornstein, Christos S. Mantzoros, et al.
Obesity Reviews (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 12
The significance of metabolism-associated steatotic liver disease and its treatment
Adam Vašura, Evžen Machytka, Marek Bužga, et al.
Vnitřní lékařství (2025) Vol. 71, Iss. 1, pp. 29-36
Closed Access
The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases
Eliane Münte, Phillipp Hartmann
Biomolecules (2025) Vol. 15, Iss. 4, pp. 469-469
Open Access
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin‐Nan Cheng, Wen‐Jone Chen, Charles Jia‐Yin Hou, et al.
Clinical and Molecular Hepatology (2023) Vol. 30, Iss. 1, pp. 16-36
Open Access | Times Cited: 10
Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future
Geltrude Mingrone, Harith Rajagopalan
Diabetes Research and Clinical Practice (2024) Vol. 211, pp. 111651-111651
Closed Access | Times Cited: 3
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis
Marina Takawy, Manal F. Abdelmalek
Current Diabetes Reports (2025) Vol. 25, Iss. 1
Closed Access
Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
Anja Geerts, Sander Lefere
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S276-S285
Open Access | Times Cited: 15
S2k-Leitlinie Klinische Ernährung in der Hepatologie
Mathias Plauth, Lars P. Bechmann, Donata Grajecki, et al.
Aktuelle Ernährungsmedizin (2024) Vol. 49, Iss. 04, pp. 256-317
Closed Access | Times Cited: 2
Regression of Hepatic Fibrosis After Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease
Pichamol Jirapinyo, Stephen D. Zucker, Christopher C. Thompson
The American Journal of Gastroenterology (2022) Vol. 118, Iss. 6, pp. 983-990
Closed Access | Times Cited: 10
Updates in Endoscopic Bariatric and Metabolic Therapies
Hammad Qureshi, Naba Saeed, Manol Jovani
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 1126-1126
Open Access | Times Cited: 6
Obesity and Metabolic Dysfunction-associated Fatty Liver Disease: Understanding the Intricate Link
Jayavardhan Vulchi, Varun Suryadevara, Pazhanivel Mohan, et al.
Journal of Translational Gastroenterology (2023) Vol. 1, Iss. 2, pp. 74-86
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top